A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma

Pak, Ekaterina; MacKenzie, Ethan L.; Zhao, Xuesong; Pazyra-Murphy, Maria F.; Park, Paul M. C.; Wu, Lei; Shaw, Daniel L.; Addleson, Emily C.; Cayer, Suzanne S.; Lopez, Begona G-C; Agar, Nathalie Y. R.; Rubin, Lee L.; Qi, Jun; Merk, Daniel J.; Segal, Rosalind A.

Publication services
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
View Item

« back

A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma

Author:

Pak, Ekaterina; MacKenzie, Ethan L.; Zhao, Xuesong; Pazyra-Murphy, Maria F.; Park, Paul M. C.; Wu, Lei; Shaw, Daniel L.; Addleson, Emily C.; Cayer, Suzanne S.; Lopez, Begona G-C; Agar, Nathalie Y. R.; Rubin, Lee L.; Qi, Jun; Merk, Daniel J.; Segal, Rosalind A.

Tübinger Autor(en):

Merk, Daniel J.

Published in:

Neuro - Oncology (2019), Bd. 21, H. 9, S. 1150-1163

Verlagsangabe:

Oxford Univ Press Inc

Language:

English

Full text:

http://dx.doi.org/10.1093/neuonc/noz089

ISSN:

1523-5866